secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lucid Diagnostics Inc. (LUCD)
CIK:        0001799011
Form:       8-K
Filed at:   2024-01-30T23:59:59+00:00
Accession:  0001493152-24-004345
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PAVmed elects to receive $4.68M in Lucid common stock for management fees
-------------------------------------------------------------------------

- PAVmed issued 3,331,771 shares of Lucid common stock in lieu of $4,675,256 in fees and reimbursements.
- Fees accrued under management services and payroll reimbursement agreements from Oct 1, 2022 to Dec 31, 2022.
- PAVmed will distribute the shares to its stockholders on or before February 15, 2024.
- This unregistered equity issuance follows terms previously disclosed in the MSA and PBERA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799011/000149315224004345/0001493152-24-004345-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799011/000149315224004345/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-004345

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer